Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis

作者: Shuyang Sun , Zuolin Wang

DOI: 10.1002/IJC.25927

关键词:

摘要: c-Met, the tyrosine kinase receptor for hepatocyte growth factor, is overexpressed in a variety of tumors which it plays central role malignant transformation. Although c-Met has also been determined to be critical signaling molecule normal stem cell function, potential as single marker cancer cells (CSCs) not previously examined. In our study, we reported that human head neck squamous carcinoma (HNSCC) expressing were capable self-renewal and generating recapitulate heterogeneity parental tumors, isolation HNSCC using second CD44 could further enhance upon in-vivo tumorigenicity. We c-Met(+) readily make spherical colonies nonadherent culture conditions, contrast, c-Met(-) population did not; these passaged multiple times without loss colony-forming capability. Furthermore, showed have increased expression pathways are spared by cisplatin treatment responsible mediating metastasis. These results indicated serve novel CSCs at least HNSCC, highly chemoresistant metastatic capabilities them an important type better define understand their function.

参考文章(47)
Alessandra Gentile, Livio Trusolino, Paolo M. Comoglio, The Met tyrosine kinase receptor in development and cancer. Cancer and Metastasis Reviews. ,vol. 27, pp. 85- 94 ,(2008) , 10.1007/S10555-007-9107-6
Akihide Kamiya, Frank J Gonzalez, Hiromitsu Nakauchi, Identification and differentiation of hepatic stem cells during liver development Frontiers in Bioscience. ,vol. 11, pp. 1302- 1310 ,(2006) , 10.2741/1884
Simone Merlin, Stefano Pietronave, Deborah Locarno, Guido Valente, Antonia Follenzi, Maria Prat, Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of theMEToncogene Cancer Science. ,vol. 100, pp. 633- 638 ,(2009) , 10.1111/J.1349-7006.2008.01079.X
Carla Boccaccio, Paolo M. Comoglio, Invasive growth: a MET-driven genetic programme for cancer and stem cells Nature Reviews Cancer. ,vol. 6, pp. 637- 645 ,(2006) , 10.1038/NRC1912
Jin-Tang Chen, Chih-Yang Huang, Yung-Yen Chiang, Wen-Heng Chen, Shiow-Her Chiou, Chih-Yi Chen, Kuan-Chih Chow, HGF Increases Cisplatin Resistance via Down-Regulation of AIF in Lung Cancer Cells American Journal of Respiratory Cell and Molecular Biology. ,vol. 38, pp. 559- 565 ,(2008) , 10.1165/RCMB.2007-0001OC
Yu-Chih Chen, Yi-Wei Chen, Han-Shui Hsu, Ling-Ming Tseng, Pin-I Huang, Kai-Hsi Lu, Dow-Tien Chen, Lung-Kuo Tai, Ming-Chi Yung, Shih-Ching Chang, Hung-Hai Ku, Shih-Hwa Chiou, Wen-Liang Lo, None, Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochemical and Biophysical Research Communications. ,vol. 385, pp. 307- 313 ,(2009) , 10.1016/J.BBRC.2009.05.048
Jeremy N. Rich, Shideng Bao, Chemotherapy and Cancer Stem Cells Cell Stem Cell. ,vol. 1, pp. 353- 355 ,(2007) , 10.1016/J.STEM.2007.09.011
Israel Cañadas, Federico Rojo, Montserrat Arumí-Uría, Ana Rovira, Joan Albanell, Edurne Arriola, C-MET as a new therapeutic target for the development of novel anticancer drugs Clinical & Translational Oncology. ,vol. 12, pp. 253- 260 ,(2010) , 10.1007/S12094-010-0501-0
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona HM Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl, None, Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. ,vol. 66, pp. 9339- 9344 ,(2006) , 10.1158/0008-5472.CAN-06-3126
M. E. Prince, R. Sivanandan, A. Kaczorowski, G. T. Wolf, M. J. Kaplan, P. Dalerba, I. L. Weissman, M. F. Clarke, L. E. Ailles, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 973- 978 ,(2007) , 10.1073/PNAS.0610117104